FDA to streamline approvals for generic biological drugs in latest move targeting health costs

The U.S. Food and Drug Administration will take steps to streamline the process to develop generic versions of complex ...

Merck Reports Earnings Under Shadow of Keytruda Patent Cliff. What to Expect.

Merck shares have floundered this year, as the company speeds like a whistling locomotive toward the expiration of the ...